INDIANAPOLIS, Feb. 17, 2021 /PRNewswire/ -- Tirzepatide led to significant A1C and body weight reductions from baseline in adults with type 2 diabetes in...
RED BANK, NJ, April 27, 2021 / PRNewswire / - Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company devoted to catching and preventing immune-mediated...